OncoSil Medical Ltd (AU:OSL) has released an update.
OncoSil Medical Ltd has reported the successful surgical removal of a pancreatic tumor in Türkiye, after treatment with their OncoSil™ device, marking a breakthrough in pancreatic cancer care. This achievement demonstrates the device’s capacity to shrink previously inoperable tumors to a resectable size, enhancing traditional chemotherapy effects. This development could signify a major advance in treatment options for patients worldwide, as the company continues to expand globally.
For further insights into AU:OSL stock, check out TipRanks’ Stock Analysis page.
